Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Shares Shorted: Short Interest Up 76.0% in October

Posted by Latisha Jones on Nov 1st, 2026

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 97,838 shares, an increase of 76.0% from the September 30th total of 55,588 shares. Based on an average daily volume of 86,848 shares, the days-to-cover ratio is currently 1.1 days. Approximately 0.0% of the company’s stock are sold short.

Sernova Biotherapeutics Price Performance

SEOVF stock opened at $0.08 on Friday. The firm has a market capitalization of $28.66 million, a P/E ratio of -1.90 and a beta of 0.89. The business’s 50-day moving average is $0.08 and its two-hundred day moving average is $0.10. Sernova Biotherapeutics has a 1 year low of $0.06 and a 1 year high of $0.14.

Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last announced its quarterly earnings data on Thursday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01).

Sernova Biotherapeutics Company Profile

(Get Free Report)

Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body.

Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.